SmileDirectClub Reports Second Quarter 2022 Financial Results
Adjusted EBITDA And CapEx Improvements Drove Improving Cash Flow
Second Quarter 2022 Financial Highlights
- Total revenue of
$126 million, a 17.0% decrease over the first quarter of 2022 and a decrease of 27.8% over the prior year period.
- Net loss of
$(65) million, an improvement of $8 millionover the first quarter of 2022 and decrease of $10 millionover the prior year period.
- Adjusted EBITDA of
$(23) million, an $11 millionimprovement over the first quarter of 2022, and a decrease of $1 millionover the prior year period.
- Diluted EPS of
$(0.17), an improvement of $0.02over the first quarter of 2022 and a decrease of $0.03over the prior year period.
- Net cash used in operating activities was
$(18) million, an improvement of $43 millionover the first quarter of 2022 and an improvement of $13 millionover the prior year period.
- Free Cash Flow defined as net cash used in operating activities less net cash used in investing activities of
$(36) million, an improvement of $41 millionover the first quarter of 2022 and an improvement of $18 millionover the prior year period.
Key Operating Metrics and Strategic Highlights
- Second quarter unique aligner shipments of 62,705, a 17.8% sequential decrease over 76,254 shipments in the first quarter of 2022.
- Second quarter average aligner gross sales price (“ASP”) of
$1,917compared to $1,890for the first quarter of 2022.
“Despite top line challenges, our cost control actions taken in the first quarter reduced our expense base and minimized the impact to our bottom line, while delivering an improving cash flow result during the second quarter,” said
Katzman added, “A key step in leveraging our technology innovations will be the rollout of our mobile scanning app for 3D treatment planning as part of our SmileMaker Platform. This is our proprietary smartphone-based scanning app with AI technology that allows customers to scan their teeth using their smartphone to see their 3D draft treatment plan for their new smile, learn how long it will take to straighten their teeth, and purchase within minutes of downloading our application. This technology delivers on our founders’ original vision of making it easy to get started with treatment, and no other clear aligner option out there can do what we have developed. This transformative innovation improves the customer experience and reduces the timeline between site visit and purchase decision that exists today.
“This new go-to-market strategy transforms
SmileDirectClub’s mission is to democratize access to a smile each and every person loves and deserves by making it affordable and convenient for everyone. The aspirational vision of the organization is to become the “world’s leading oral health brand by helping more people realize the life changing potential of a confident smile.” SmileDirectClub’s vision and mission are greater than manufacturing and marketing clear aligners. Every decision and investment the Company has made is to support and expand this mission and enable its long-term growth potential. For
The Company has been issued 43 patents and counting for its innovations in orthodontic treatment planning, aligner manufacturing, smile scanning technologies, its proprietary telehealth platform and a variety of other areas. There are many more patents pending and in the pipeline in both the US and abroad on various technologies relating to data capture, 3D image capture, intraoral scanning, monitoring, manufacturing, and consumer products. In addition, the Company has enabled treatment for over 1.7 million customers, built the only end-to-end vertically integrated platform for the consumer at scale, created a dental Partner Network with 690 global practices that are live or pending training, created oral care products available at over 16,300 retail stores worldwide, and remains the strongest teledentistry brand with 57% aided awareness.
When consumers are considering straightening their teeth, they typically do one or all of the following: search online to understand their options; ask a dentist; and ask a friend or family member which option they should choose. Based on the Company’s research, consumers have noted its product and customer experience is nearly identical to Invisalign, less expensive, and more convenient. For other teledentistry platforms, its research showed that significantly fewer customers would recommend those brands compared with
In addition to these investments to create the next generation of oral care and influence consumer decision making, the Company will continue to make strategic investments in penetrating new demographics to drive controlled growth, while also executing against its profitability goals. Lastly, favorable industry dynamics continue to increase with broader acceptance of telehealth and specifically teledentistry, minimal penetration against the total addressable market, a number of recent regulatory wins that should help remove barriers to access to care, and clear aligners gaining share in the overall industry.
Revised Full Year 2022 Guidance
Challenges to consumer spending accelerated faster than we anticipated during the quarter which, combined with reduced stimulus, sustained high inflation, and a shift in discretionary spending towards services have resulted in less predictable demand curves and lower overall expected demand for the balance of the year.
For the year ended
The full year 2022 costs and capital outlook include (see Company’s supplemental earnings presentation for more insights regarding these assumptions):
- Gross margin range (as a percentage of total revenues) of 69.5% to 71.5%
- Adjusted EBITDA range of (
$180 million) to ( $140 million)
- CapEx range of
$60 millionto $70 million
- One-time costs range of
$20 millionto $25 million
- Year-end cash balance between
$120 millionto $160 million
Revenue and expense guidance updates now include contributions and investments for accelerated expansion of the Partner Network and SmileShop footprint expansion.
Conference Call Information
|SmileDirectClub Second Quarter 2022 Conference Call Details|
|Dial-In:||1-877-407-9208 (domestic) or 1-201-493-6784 (international)|
|Webcast:||Visit “Events and Presentations” section of the company’s IR page at http://investors.smiledirectclub.com|
A replay of the call may be accessed the same day from 11 a.m. Eastern Time on Tuesday, August 9, 2022 until 11:59 p.m. Eastern Time on Tuesday, August 16, 2022 by dialing 1-844-512-2921 (domestic) or 1-412-317-6671 (international) and entering the replay PIN: 13730975. A copy of the second quarter 2022 results supplemental earnings presentation and an archived version of the call, when completed, will also be available on the Investor Relations section of SmileDirectClub’s website at investors.smiledirectclub.com.
This earnings release contains forward-looking statements. All statements other than statements of historical facts may be forward-looking statements. Forward-looking statements generally relate to future events and include, without limitation, projections, forecasts and estimates about possible or assumed future results of our business, financial condition, liquidity, results of operations, plans, and objectives. Some of these statements may include words such as “expects,” “anticipates,” “believes,” “estimates,” “targets,” “plans,” “potential,” “intends,” “projects,” and “indicates.”
Although they reflect our current, good faith expectations, these forward-looking statements are not a guarantee of future performance, and involve a number of risks, uncertainties, estimates, and assumptions, which are difficult to predict. Some of the factors that may cause actual outcomes and results to differ materially from those expressed in, or implied by, the forward-looking statements include, but are not necessarily limited to: the ongoing assessment of the cyber incident, material legal, financial and reputational risks resulting from such incident and the related operational disruptions; the duration and magnitude of the COVID-19 pandemic and related containment measures; our management of growth; the execution of our business strategies, implementation of new initiatives, and improved efficiency; our sales and marketing efforts; our manufacturing capacity, performance, and cost; our ability to obtain future regulatory approvals; our financial estimates and needs for additional financing; consumer acceptance of and competition for our clear aligners; our relationships with retail partners and insurance carriers; our R&D, commercialization, and other activities and expenditures; the methodologies, models, assumptions, and estimates we use to prepare our financial statements, make business decisions, and manage risks; laws and regulations governing remote healthcare and the practice of dentistry; our relationships with vendors; the security of our operating systems and infrastructure; our risk management framework; our cash and capital needs; our intellectual property position; our exposure to claims and legal proceedings; and other factors described in our filings with the
New risks and uncertainties arise over time, and it is not possible for us to predict all such factors or how they may affect us. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. We are under no duty to update any of these forward-looking statements after the date of this earnings release to conform these statements to actual results or revised expectations. You should, therefore, not rely on these forward-looking statements as representing our views as of any date subsequent to the date of this earnings release.
Global Head, FP&A and Investor Relations
Director, Investor Relations
Senior Vice President,
Consolidated Balance Sheets
|Accounts receivable, net||166,528||184,558|
|Prepaid and other current assets||23,816||17,519|
|Total current assets||391,718||467,740|
|Accounts receivable, net, non-current||55,093||59,210|
|Property, plant and equipment, net||210,574||227,201|
|Operating lease right-of-use assets||23,825||24,927|
|LIABILITIES AND EQUITY (DEFICIT)|
|Current portion of long-term debt||6,189||10,997|
|Other current liabilities||5,921||4,997|
|Total current liabilities||154,304||178,240|
|Long-term debt, net of current portion||785,961||729,973|
|Operating lease liabilities, net of current portion||18,482||20,352|
|Other long-term liabilities||349||347|
|Class A common stock, par value
|Class B common stock, par value
|Accumulated other comprehensive income||967||293|
|Total equity (deficit)||(258,536||)||(134,354||)|
|Total liabilities and equity (deficit)||$||700,560||$||794,558|
Consolidated Statements of Operations
(in thousands, except share and per share amounts)
|Three Months Ended
||Six Months Ended
|Cost of revenues||34,075||45,860||77,141||93,821|
|Marketing and selling expenses||71,191||95,943||167,902||193,066|
|General and administrative expenses||72,320||85,042||143,113||166,120|
|Lease abandonment and impairment of long-lived assets||—||—||1,232||—|
|Restructuring and other related costs||3,168||536||14,700||1,664|
|Loss from operations||(54,958||)||(53,200||)||(126,646||)||(81,029||)|
|Loss on extinguishment of debt||—||—||—||47,631|
|Net loss before provision for income tax expense (benefit)||(65,230||)||(55,269||)||(139,897||)||(149,207||)|
|Provision for income tax expense (benefit)||256||(12||)||(1,207||)||1,695|
|Net loss attributable to noncontrolling interest||(45,181||)||(38,377||)||(95,804||)||(105,113||)|
|Net loss attributable to
|Earnings (loss) per share of Class A common stock:|
|Weighted average shares outstanding:|
Consolidated Statements of Cash Flows
|Six Months Ended
|Adjustments to reconcile net loss to net cash used in operating activities:|
|Depreciation and amortization||38,496||33,169|
|Deferred loan cost amortization||2,329||3,041|
|Loss on extinguishment of debt||—||47,631|
|Paid in kind interest expense||—||3,324|
|Asset impairment and related charges||6,300||—|
|Other non-cash operating activities||1,102||798|
|Changes in operating assets and liabilities:|
|Prepaid and other current assets||(6,377||)||(6,572||)|
|Net cash used in operating activities||(79,104||)||(59,351||)|
|Purchases of property, equipment, and intangible assets||(32,872||)||(45,303||)|
|Net cash used in investing activities||(32,872||)||(45,303||)|
|Repurchase of Class A shares to cover employee tax withholdings||(2,340||)||(6,260||)|
|Proceeds from stock purchase plan||429||632|
|Repayment of HPS Credit Facility||—||(396,497||)|
|Payment of extinguishment costs||—||(37,701||)|
|Borrowings of long-term debt||54,920||747,500|
|Payments of issuance costs||(5,426||)||(21,179||)|
|Purchase of capped call transactions||—||(69,518||)|
|Final payment of Align arbitration||—||(43,400||)|
|Principal payments on long-term debt||—||(4,609||)|
|Payments of finance leases||(4,808||)||(5,182||)|
|Net cash provided by financing activities||45,328||163,703|
|Effect of exchange rates change on cash and cash equivalents||52||875|
|Increase (decrease) in cash||(66,596||)||59,924|
|Cash at beginning of period||224,860||316,724|
|Cash at end of period||$||158,264||$||376,648|
Use of Non-GAAP Financial Measures
This earnings release contains certain non-GAAP financial measures, including adjusted EBITDA (“Adjusted EBITDA”) and Free Cash Flow. We provide a reconciliation of these non-GAAP financial measures to the most directly comparable GAAP financial measures below and in our Current Report on Form 8-K announcing our quarterly earnings results, which can be found on the SEC’s website at www.sec.gov and our website at investors.smiledirectclub.com.
We utilize certain non-GAAP financial measures, including Free Cash Flow and Adjusted EBITDA, to evaluate our actual operating performance and for the planning and forecasting of future periods.
We define Free Cash Flow as net cash used in operating activities less net cash used in investing activities.
We define Adjusted EBITDA as net loss, plus depreciation and amortization, interest expense, income tax expense (benefit), equity-based compensation, loss on extinguishment of debt, impairment of long-lived assets, abandonment and other related charges and certain other non-operating expenses, such as one-time store closure costs associated with our real estate repositioning strategy, severance, retention and other labor costs, certain one-time legal settlement costs, and unrealized foreign currency adjustments. We use Adjusted EBITDA when evaluating our performance when we believe that certain items are not indicative of operating performance. Adjusted EBITDA provides useful supplemental information to management regarding our operating performance, and we believe it will provide the same to members/stockholders.
We believe that Adjusted EBITDA will provide useful information to members/stockholders about our performance, financial condition, and results of operations for the following reasons: (i) Adjusted EBITDA is among the measures used by our management team to evaluate our operating performance and make day-to-day operating decisions and (ii) Adjusted EBITDA is frequently used by securities analysts, investors, lenders, and other interested parties as a common performance measure to compare results or estimate valuations across companies in our industry.
Adjusted EBITDA does not have a definition under GAAP, and our definition of Adjusted EBITDA may not be the same as, or comparable to, similarly titled measures used by other companies. Adjusted EBITDA should not be considered in isolation from, or as a substitute for, financial information prepared in accordance with GAAP.
A reconciliation of both Free Cash Flow and Adjusted EBITDA to net loss, the most directly comparable GAAP financial measure for Adjusted EBITDA, is set forth below.
Reconciliation of Free Cash Flow
|Three Months Ended|
|Net cash used in operating activities||$||(17,840||)||$||(61,264||)||$||(31,013||)|
|Net cash used in investing activities||(17,754||)||(15,118||)||(22,322||)|
|Free Cash Flow||$||(35,594||)||$||(76,382||)||$||(53,335||)|
Reconciliation of Net Loss to Adjusted EBITDA
|Three Months Ended||Six Months Ended|
|Depreciation and amortization||19,580||18,916||16,709||38,496||33,169|
|Total interest expense||4,454||1,556||1,939||6,010||19,505|
|Income tax expense (benefit)||256||(1,463||)||(12||)||(1,207||)||1,695|
|Lease abandonment and impairment of long-lived assets||—||1,232||—||1,232||—|
|Restructuring and other related costs||3,168||11,532||536||14,700||1,664|
|Loss on extinguishment of debt||—||—||—||—||47,631|
|Other non-operating general and administrative losses||6,306||1,684||1,601||7,990||2,513|
Source: SmileDirectClub, LLC